Compounding news

Exclusive—Dr. Michael C. Burgess: We Need a New Playbook to Guard Against Counterfeit Drug Ingredients from China

RX Border Defense

Novo Nordisk secures injunction over Ozempic, Wegovy claims

Centric Compounding Issues Nationwide Recall of Glutathione, Myer’s Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels

Compounded Semaglutide and Tirzepatide Have Drawn More Than 1,700 Federal Problem Reports as Peptide Sales Climb

$elling $kinny: How a weight-loss startup kept shipping risky diet drugs while patients landed in the hospital

Fewer Than One in Four New Compounding Facilities Were Inspected, and Every Inspected Site Had Violations

Surge in unapproved GLP-1 drugs alarming poison control, safe medicine advocates

The peptide surge has reached compounding - Australian Pharmacist

FDA reminds compounders not to use dietary supplement grade glutathion

A Second Texas Pharmacy Recalls Compounded Glutathione Injections Across Fourteen States Over Elevated Bacterial Toxin Levels

A quantitative and qualitative study of US FDA inspection reports of 503B outsourcing facilities

Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd. - 731761 - 08/06/2026

Navigating Compounding Peptides and GLP-1s Through Regulations | Drug Topics

Statement from Partnership for Safe Medicines on new litigation alleging illegal distribution of retatrutide

One Year Later: What the Compounding Industry Taught Us About Regulatory Compliance

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

GLP-1 Solution - 715883 - 09/09/2025 | FDA

Compound pharmacies need more oversight as growth soars, experts say

Mail-order pharmacy faces charges from Iowa regulators • Iowa Capital Dispatch

Summary Suspension Notice: Grand Ave Pharmacy, Pflugerville, Texas

District of New Jersey | Former pharmacy president sentenced to 24 months in prison for health care fraud and kickback scheme involving compounded medications | United States Department of Justice

Office of Public Affairs | Texas doctor sentenced to 8.5 years in prison for $145 million health care fraud scheme | United States Department of Justice

Revive Rx LLC dba Revive Rx Pharmacy - 709509 - 09/22/2025 | FDA

Staska Pharmaceuticals, Inc. - 699291 - 05/05/2025 | FDA

Iowa board files charges against mail-order pharmacy cited by FDA and California board

Warning Letter OSRX, Inc. MARC-CMS 701889

FDA probes compounding pharmacies over quality concerns - Becker's Hospital Review | Healthcare News & Analysis

Empower Clinic Services, LLC dba Empower Pharma - 700962 - 04/02/2025 | FDA

Annovex Pharma, Inc. - MARCS-CMS 698115